Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Short Communication
Nestin: A Biomarker of Aggressive Uterine Cancers
Erica R Hope1-3, Chad A Hamilton1-4, Paulette Mhawech-Fauceglia5, Tanja Pejovic6, G Larry Maxwell2-4,7, Viqar Syed3 and Kathleen M Darcy2-4*1Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD, USA
2Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, VA, USA
3Department of Obstetrics and Gynecology, Uniformed Services University, 4301 Jones Bridge Road, Bethesda, MD, USA
4John P Murtha Cancer Center, 8901 Wisconsin Avenue, Bethesda, MD, USA
5Department of Pathology, University of Southern California, 1100 N. State Street, Los Angeles, CA, USA
6Department of Obstetrics and Gynecology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, L466, Portland, OR, USA
7Department of Obstetrics and Gynecology, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA, USA
- *Corresponding Author:
- Kathleen M Darcy
Gynecologic Cancer Center of Excellence
3289 Woodburn Road, Suite 370
Annandale VA 22003, USA
Tel: 571-205-2607
Fax: 703-560-0919
E-mail: DarcyK@WHIRC.org
Received Date: Jul 06, 2016; Accepted Date: Aug 03, 2016; Published Date: Aug 10, 2016
Citation: Hope ER, Hamilton CA, Fauceglia PM, Pejovic T, Maxwell GL, et al. (2016) Nestin: A Biomarker of Aggressive Uterine Cancers. Trends Gynecol Oncol 1: 108.
Copyright: © 2016 Hope ER, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
